SHR7280
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for SHR7280, covering 2024-01-24 to 2025-09-10. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1 Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, Omeprazole, Digoxin, and Rosuvastatin in Healthy Subjects [Phase 1]